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SUMMARY
Parasitic infections caused by intestinal protozoan and helminths affect more than two billion people worldwide and chemotherapy
is the most commonly used therapeutic procedure. Considering the problems created by parasitic infections and the incorrect use of
drugs, the aim of this work was to detect the frequency of enteroparasites infection and to estimate the use of chemotherapeutic agents
in children living in the periphery of the city of Porto Alegre, RS, Brazil. Ninety-six preschool age children, who had parasitological
exams and who used antiparasitic drugs, were analyzed. The efficacy of treatment was evaluated by stool examination repeated six
months after treatment. The same diagnostic test was used to evaluate parasitological cure, which was defined as absence of eggs and
cysts in the stool. From these children, 79 (82.3%) were contaminated by some species of parasite, the most prevalent were Ascaris
lumbricoides, Trichuris trichiura and Giardia lamblia. The most commonly used drugs were mebendazole (86% of prescriptions)
and metronidazole (30.3%). The cure rate in the 79 children, examined 6 months after treatment, was 65.3% for A. lumbricoides and
66.1% for T. trichiura. This study suggests that a continuous education program regarding the prevention and treatment of parasitic
infections is an essential tool for their eradication.
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INTRODUCTION
Parasitic infections, caused by intestinal protozoan and helminths,
affect more than two billion people worldwide28. These infections are
more prevalent in the poorest sections of the population and re-infection
in endemic areas is continuous5,6. According to the WHO, 980 million
people are infected with intestinal roundworm Ascaris lumbricoides28.
Several studies show that the prevalence of A. lumbricoides and Trichuris
trichiura is very high in the patients examined, when compared with
other parasites such as Giardia lamblia, Strongyloides stercoralis,
Hymenolepis nana and others4,8,9,10,17,21,22,27.
Among the conditions influencing the development of these
infections are poor sanitary conditions, lowering resistance of the host,
population explosion, inadequate control of vectors and infection of
reservoirs, increased migration, military operation and travelling around
the world15,20,24. This disease can undermine child development,
educational achievement, reproductive health and social and economic
development1,3 and some parasitic infections can cause morbidity and
mortality14. Nevertheless, treatment is often neglected for economic
reasons and because most patients have no symptoms1.
Chemotherapy is the cornerstone of the strategy of control of
morbidity, reduction of transmission and delay of soil-transmitted
helminth re-infection3,11. The benzimidazole antihelminthics are largely
used for treating intestinal nematode infection together with praziquantel
for schistosomiasis7,16,19. These drugs are safe, inexpensive and very
effective, have a broad-spectrum of activity, and easy administration3,15.
Anthelminthic resistance may develop more slowly than in other agents,
although, a recent study indicates that benzimidazole resistance has
developed in hookworms after treatment of infected patients11.
Chemotherapy is the most used therapeutic procedure, however, many
treatments do not obtain their goal due to the incorrect use of drugs25.
Tests on the efficacy of chemotherapeutic agents can be used, these
include cure rate, egg-reduction rate and the occurrence of any side effects
due to administration of the drugs.
Therefore, actions by the health professional are necessary to provide
adequate clinical care within the health system28. Pharmacists, in the
modern health system, also have a responsibility to provide patient
education regarding treatment as well as diagnostic investigation12.
According to OLSEN et al., health education is an important factor in
the prevention of parasitic infections20.
Considering the problems created by parasitic infections and the
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incorrect use of drugs, the aim of this work was to detect the frequency
of enteroparasites infection and to estimate the use of chemotherapeutic
drugs in children living in the periphery of Porto Alegre, RS, Brazil.
MATERIALS AND METHODS
Population: Prospective data collection was performed during the
year 2002-2003. Ninety-six children of pre-school age and of both sexes
were analyzed, children were chosen randomly from the patients of a
Public Health Center, Porto Alegre, RS, Brazil.
Diagnostic test: The fecal specimens were collected and screened
for a complete ova and parasite examination (O&P) by the gravity
sedimentation technique13,16 and the Baermann method2. One sample from
each patient was examined within a period of 12 h after the collection
and parents signed an informed consent form. Immediately after the
stool examination, treatment was given to the children with positive stool
findings. The efficacy of treatment was evaluated by stool examination
repeated six months after treatment. The same diagnostic test was used
to evaluate parasitological cure, which was defined as absence of eggs
and cysts in the stool.
Pharmaceutical care program: After the prescription of medication,
an interview was performed with the patients and their parents. The
questionnaire contained information on the patient’s age, habits,
prescribed drugs, and treatment regimen. The Pharmaceutical Care
Program provided the patients and parents with information about basic
health hygiene notions, drug prescriptions and the correct use of drugs.
This study was approved by the Institutional Ethics Committee.
Data analysis: The data were collected and the results were kept in
individual patient files together with the diagnostic tests, the
questionnaires and interventions realized. The computer program,
Epiinfo, was used to analyze the data and cure rate was presented as the
percentage of the data set.
RESULTS
In this survey, 96 children of pre-school age were investigated. Table
1 shows the characteristics of children infected, where the mean age of
the female infected was 4.43 (± 2.36) and the non-infected was 3.14
(± 1.77). The mean age of the infected male children was 4.45 (± 2.65)
and the non-infected was 2.62 (± 3.06). The total number of infected
children before treatment was 79 (82.3%) and 17 (17.7%) non-infected.
Of these, 46 (47.9%) were female infected children and 7 (7.3%) non-
infected. The total number of male children infected was 33 (34.4%)
and non-infected males was 10 (10.4%) (Table1).
According to the results, 79 (82.3%) children were contaminated by
some parasite. Table 2 shows the distribution of the specific
enteroparasites, the most prevalent parasites were A. lumbricoides (49;
62%), T. trichiura (46; 58.2%) and G. lamblia (16; 20.3%) (Table 2).
The children were infected with Hymenolepis nana, Strongyloides
stercoralis and other protozoa.
Table 3 depicts the chemotherapeutic agents most commonly used
in the infected patients. Of the 79 infected patients that received treatment
with one or more chemotherapeutic agent, 68 (86.1%) received
anthelminthic mebendazole, 24 (30.4%) patients received metronidazole,
5 (6.3%) patients received praziquantel and 3 (3.8%) patients received
anthelminthic tiabendazole. The most used drug was mebendazole with
a treatment regimen of 600 mg multiple-dose (2 X 100 mg over three
days). Other drug regimens used were 5 mg/kg three times a day during
five to seven days for metronidazole to treat Giardia lamblia, and
10 mg/kg three times a day for five to seven days to treat Entamoeba.
Praziquantel was used at 50 mg/kg once a day for Hymenolepis nana.
To treat Strongyloides stercoralis, tiabendazole (25 mg/kg) was
administered twice daily for two days (Table 3).
Table 1
Sex and age composition prevalence, and intensity of parasites among pre-
school age children in an urban slum, Porto Alegre, RS (n = 96)
Sex  Negative cases  Positive cases
Children’s age F/Ma  3.14 ± 1.77/ 4.43 ± 2.36/
2.62 ± 3.06b  4.45 ± 2.65
Female 7 (7.3%) 46 (47.9 %)
Male 10 (10.4%) 33 (34.4 %)
Total 17 (17.7%) 79 (82.3 %)
a F = female; M = male; b Mean ± SD
Table 2
Parasites distribution in pre-school age children (n = 79)
Parasites  Frequency*  Percentage (%)
Helminths
Ascaris lumbricoides 49 62.0%
Trichuris trichiura 46 58.2%
Strongyloides stercoralis 3 3.8%
Hymenolepis nana 5 6.3%
Protozoan
Entamoeba spp.** 1 1.3%
Entamoeba coli 8 10.1%
Endolimax nana 6 7.6%
Giardia lamblia 16 20.3%
*Some specimens had more than one parasite. **Entamoeba histolytica is being
used to designate pathogenic zymodemes, while E. dispar is now being used to
designate nonpathogenic zymodemes. However, unless trophozoites containing
ingested red blood cells (E. histolytica) are seen, the two organisms cannot be
differentiated on the basis of morphology.
Table 3
Various regimens of chemotherapeutic agents in the treatment of parasitic
infections (n = 79)
 Regimen of chemotherapeutic agents  Number of Percentage (%)
prescription*
600 mg mebendazole multiple dose 68 86.1%
5 mg/kg metronidazole  multiple dose 24 30.4%
50 mg/kg praziquantel single dose 5 6.3%
25 mg/kg tiabendazole  multiple dose 3 3.8%
*Some prescriptions had more than one chemotherapeutic agent prescribed.
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There was an increase in the children’s weight after the use of
pharmacotherapy where 21 (12.9%) patients demonstrated an increased
weight after treatment (data not shown).
Among the children studied the percentage cure rate at examination
6 months after treatment was 65.3% for A. lumbricoides, 66.1% for T.
trichiura and 71.5% for G. lamblia (Table 4).
DISCUSSION
According to our data, most of the children studied were found to be
infected by some species of worm. This study was performed in the
periphery of Porto Alegre, where families live in inadequate sanitary
conditions, reservoirs and vectors are infected, and food and water are
contaminated. Many children are more exposed to infections because
they have poor hygienic habits and the houses are located near rubbish
deposits. The majority of the children’s parents, who have a low income,
are analphabets, leading us to believe that the heavy intensity of worm
infection is related to the low socioeconomic level of the population
analyzed.
The high rate of use of mebendazole is justified by the high prevalence
of the two intestinal parasites, A. lumbricoides and T. trichiura, in the
children studied. It is important to mention that the Public Health Center
did not have the antihelminthic, albendazole, available and the
medications prescribed were given freely, which limited the choice of
prescription.
The pharmacological regimen used in the Public Health Center
followed a pattern largely used nowadays. All drug administrations were
by oral route, with recommended dosage and frequency of administration
according to the prescription. The children also received mineral oil,
vitamins and ferrous sulphate to avoid iron-deficiency-related anemia.
Each medication prescribed had its own drug regimen, with time of
administration and variable doses. This created some difficulties for the
parents in understanding how to administrate the drugs prescribed,
resulting some times in the non-compliance of treatment. Several studies
show that drug regimens with one single oral dose can be as effective
and safe as the conventional regimens18,19,23. Various combinations of
drugs are also suggested for the treatment of parasitic infections in some
situations26. The current chemotherapeutic agents can be used in novel
ways, whilst empiric regimens need continuous clinic evaluation, thus,
improved investigations of the use of drugs with different mechanisms
against the same parasite or broad-spectrum are needed.
Regarding medication-related problems, we found that some patients
did not receive the therapy, or did not adhere to the indicated drug regimen
because of lack of information. These problems are very common in
people living in poor hygiene and health conditions, with little food,
without education and knowledge of the importance of following
treatment. Many children examined had already received pharmacological
treatment at least six months before. The re-incidence of infection is
common twice or three times a year and, therefore, the benefits of a
continuous program for high-risk groups as well should be considered.
Nutritional status is an important factor for the adequate absorption
and action of the drugs24. The majority of patients studied were
undernourished, facilitating the process of adverse drug reactions. Thus,
a strategy to avoid those side effects in this high-risk group would be the
correct use of pharmacotherapy together with an appropriate diet. After
the treatment there was a significant increase in the weight of some of
the children (data not shown), which led us to believe that the drug
therapy was correctly used.
The high cure rate percentage found in our study confirmed the high
efficacy of the benzimidazole antihelminthic for A. lumbricoides and T.
trichiura infections. For the other parasites, geographical variations, genetic
differences in the parasites and the quality of drugs (for example low-
quality generics) used should be taken into account to explain low cure
rates3. In addition, we should look at the development of drug resistance,
which would cause a decrease in the parasites cure rate as well11.
This study suggests that additional support and a continuing health
education program, regarding prevention and treatment, is an essential
tool for the eradication of the parasitic infections.
RESUMO
Estudo da freqüência de infecções por enteroparasitos e agentes
quimioterápicos usados em pacientes pediátricos em uma
comunidade de Porto Alegre, RS, Brasil
As parasitoses provocadas por protozoários ou helmintos patogênicos
afetam mais de dois bilhões de pessoas no mundo. Considerando os
problemas gerados por infecções parasitárias e a necessidade do uso
correto dos medicamentos prescritos, o objetivo deste trabalho foi detectar
a freqüência de infecção por enteroparasitos e o uso de agentes
quimioterápicos em crianças moradoras na periferia de Porto Alegre,
RS, Brasil. Foram analisadas noventa e seis crianças em idade pré-escolar,
que realizaram o exame parasitológico de fezes e que fizeram uso de
antiparasitários. A eficácia do tratamento foi avaliada pelo exame
parasitológico repetido seis meses após o tratamento. O mesmo teste
diagnóstico foi utilizado para avaliar a cura que foi definida como a
ausência de ovos e cistos nas fezes. Das crianças estudadas, 79 (82,3%)
estavam infectadas com um ou mais parasitas, os mais prevalentes foram
Ascaris lumbricoides, Trichuris trichiura e Giardia lamblia. Os
antiparasitários mais utilizados foram mebendazol (86% das prescrições)
e metronidazol (30,3%) de acordo com a prevalência da infecção. A
porcentagem de cura das 79 crianças estudadas após 6 meses do
tratamento foi 65,3% para A. lumbricoides e 66,1% para T. trichiura.
Este estudo sugere que um programa de educação continuada voltado
para a prevenção e tratamento das infecções parasitárias tem se mostrado
uma ferramenta útil na erradicação destas patologias.
Table 4
Comparison between the intensity of Ascaris lumbricoides, Trichuris trichiura
and Giardia lamblia infection in the pre- and post-treatment period in an
urban slum, Porto Alegre, RS (n = 79)
Parasitic prevalence (%)
Type of infection Pre-treatment Post-treatment CR (%)
A. lumbricoides 62.0% 34.7% 65.3%
T. trichiura 58.2% 33.9% 66.1%
G. lamblia 20.3% 18.5% 71.5%
CR = cure rate; defined as absence of eggs in the stool after treatment.
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